Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8


Journal

Drug delivery and translational research
ISSN: 2190-3948
Titre abrégé: Drug Deliv Transl Res
Pays: United States
ID NLM: 101540061

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 23 6 2019
medline: 2 4 2020
entrez: 23 6 2019
Statut: ppublish

Résumé

Poly(lactic-co-glycolic) acid (PLGA) has been successfully used in drug delivery and biomaterial applications, but very little attention has been directed towards the potential in vivo effects of peptide-loaded PLGA nanoparticles (NPs), specifically the potency of intravenous (IV) STEAP peptide-loaded PLGA-NP (nanovaccine) dosing and whether STEAP-specific CD8

Identifiants

pubmed: 31228097
doi: 10.1007/s13346-019-00652-z
pii: 10.1007/s13346-019-00652-z
doi:

Substances chimiques

Antigens, Neoplasm 0
Cancer Vaccines 0
Steap protein, mouse 0
Polylactic Acid-Polyglycolic Acid Copolymer 1SIA8062RS

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1095-1105

Références

Hum Vaccin Immunother. 2016 Apr 2;12(4):1056-69
pubmed: 26752261
Cancers (Basel). 2019 Feb 14;11(2):null
pubmed: 30769871
Am J Cancer Res. 2018 Jun 01;8(6):916-931
pubmed: 30034931
Vaccine. 2012 Oct 19;30(47):6609-11
pubmed: 23067445
Nat Nanotechnol. 2007 Dec;2(12):751-60
pubmed: 18654426
Prostate. 2016 Apr;76(5):456-68
pubmed: 26715028
Int J Cancer. 2004 Nov 1;112(2):335-40
pubmed: 15352049
Eur J Pharm Biopharm. 2013 Apr;83(3):338-45
pubmed: 23201055
Cancer Immunol Immunother. 2016 Jun;65(6):701-13
pubmed: 27052571
Oncoimmunology. 2015 Aug 12;5(1):e1068493
pubmed: 26942088
Nat Immunol. 2015 Jan;16(1):36-44
pubmed: 25521683
Adv Drug Deliv Rev. 2005 Jan 10;57(3):475-82
pubmed: 15560953
Int J Nanomedicine. 2012;7:1475-87
pubmed: 22619507
Immunology. 2017 Nov;152(3):462-471
pubmed: 28664991
J Biomed Sci. 2017 Mar 21;24(1):21
pubmed: 28320393
Cancer Res. 2016 Jul 1;76(13):3711-8
pubmed: 27216195
Colloids Surf B Biointerfaces. 2005 Mar 25;41(2-3):117-20
pubmed: 15737536
Clin Cancer Res. 2005 Jun 15;11(12):4545-52
pubmed: 15958640
Adv Exp Med Biol. 2018;1096:185-194
pubmed: 30324354
J Transl Med. 2011 Nov 05;9:191
pubmed: 22053850
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18636-41
pubmed: 18003899
Immune Netw. 2013 Feb;13(1):30-3
pubmed: 23559898
Vaccine. 2008 Sep 15;26(39):5046-57
pubmed: 18680779
Core Evid. 2014 Dec 18;10:1-10
pubmed: 25565923
Sci Rep. 2015 Jun 03;5:10881
pubmed: 26039249
Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14523-8
pubmed: 10588738
Int Immunopharmacol. 2017 Jun;47:159-165
pubmed: 28410529
Cell. 2015 Apr 9;161(2):201-4
pubmed: 25860604
Vaccine. 2013 Jan 11;31(4):596-602
pubmed: 23219438
PLoS One. 2013 Apr 22;8(4):e62500
pubmed: 23614052
Nanotechnology. 2012 Aug 17;23(32):325101
pubmed: 22824940
Cells. 2017 Dec 07;6(4):null
pubmed: 29215603
Clin Transl Oncol. 2015 May;17(5):339-57
pubmed: 25480118
Immunotargets Ther. 2017 Mar 20;6:11-16
pubmed: 28361045
N Engl J Med. 2004 Oct 7;351(15):1502-12
pubmed: 15470213
J Transl Med. 2011 Mar 31;9:34
pubmed: 21450109
BMC Biol. 2017 Jun 29;15(1):53
pubmed: 28662662
J Urol. 2010 May;183(5):2036-44
pubmed: 20303532
Cancer Immunol Immunother. 2006 Dec;55(12):1515-23
pubmed: 16622681
Prostate Int. 2018 Dec;6(4):119-125
pubmed: 30505813
J Biomed Sci. 2015 Oct 20;22:89
pubmed: 26482775
Curr Pharm Des. 2018;24(43):5164-5174
pubmed: 30657037
Nanomedicine (Lond). 2018 Apr;13(8):913-928
pubmed: 29527969
Clin Exp Vaccine Res. 2014 Jul;3(2):113-6
pubmed: 25003083

Auteurs

Qiuqiang Chen (Q)

Key Laboratory for Translational Medicine, The First Affiliated Hospital of Huzhou University School of Medicine, Huzhou, 313000, Zhejiang, China.
Department of Clinical Medicine, Huzhou University School of Medicine, Huzhou, 313000, Zhejiang, China.

Ying Bao (Y)

Key Laboratory for Translational Medicine, The First Affiliated Hospital of Huzhou University School of Medicine, Huzhou, 313000, Zhejiang, China.

Danielle Burner (D)

Department of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, CA, 92093, USA.

Sharmeela Kaushal (S)

Department of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, CA, 92093, USA.

Yu Zhang (Y)

Materials Science and Engineering Program, Department of Mechanical Engineering, University of California Riverside, Riverside, CA, 92521, USA.
Mechanical and Automotive Engineering, School of Engineering, RMIT University, Melbourne, Victoria, 3083, Australia.

Theresa Mendoza (T)

Department of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, CA, 92093, USA.

Michael Bouvet (M)

Department of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, CA, 92093, USA.

Cengiz Ozkan (C)

Materials Science and Engineering Program, Department of Mechanical Engineering, University of California Riverside, Riverside, CA, 92521, USA.

Boris Minev (B)

Department of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, CA, 92093, USA. bminev@ucsd.edu.
Calidi Biotherapeutics, San Diego, CA, 92121, USA. bminev@ucsd.edu.

Wenxue Ma (W)

Department of Clinical Medicine, Huzhou University School of Medicine, Huzhou, 313000, Zhejiang, China. wma@ucsd.edu.
Department of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, CA, 92093, USA. wma@ucsd.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH